Our CEO Pascal Soriot shares our strong 2024 performance with continued double-digit growth and scientific progress across all Therapy Areas. We're also pleased to announce that AstraZeneca’s total annual dividend has increased by 7% to $3.10 per share and will further increase in 2025. This momentum reflects the great work of our teams to deliver for people, society and the planet. #WhatScienceCanDo
This year we are excited to celebrate our 25th anniversary with our teams around the world! We are pleased to report 2023 was another year of double-digit growth and scientific progress, with investments in exciting areas of science that lay the foundations for continued long-term success. We are committed to unlocking the power of what science can do for people, society and the planet.
Meet our Talent Acquisition team from across the globe. We’re still recruiting and utilising digital capabilities, so we can continue to hire great talent with a passion to make a potential difference to patients lives. http://bit.ly/2JS9wnc
AstraZeneca CEO Pascal Soriot speaks with Julia Chatterley of First Move (CNN) regarding the latest developments in the research and development of a COVID-19 vaccine.
A #COVID19 vaccine is crucial to helping us overcome this global pandemic. That is why we are partnering with the University of Oxford to support the global development, manufacturing and distribution of the University’s vaccine candidate if it proves to be effective.
In response to #COVID19, teams across AstraZeneca have moved quickly to maintain continuity of care, contribute to society, and use our scientific expertise to fight the pandemic. https://bit.ly/3f5gNO6
Today we’re announcing results from a robust first quarter and our ongoing efforts to advance science in the fight against #COVID19: https://bit.ly/2VJCzix
To support our leaders and employees in navigating the current challenges, we created COVID-19 toolkits, and have now made these available externally for anyone to download! Please access our AstraZeneca COVID-19 Information Hub to access these great resources. #greatplacetowork
The health and wellbeing of our employees and candidates is paramount to us at AstraZeneca. During the COVID-19 pandemic, we’re leveraging digital capabilities to ensure we can continue to recruit great talent while adhering to local health guidance.
New year, new career? From science to business, there are opportunities across the globe to make a difference to patient lives. What impact will you make in 2020?
Check out your Company Bowl for anonymous work chats.
